Michael Geffner Immunovant, Inc. (IMVT) insider trading activity

IMVT Quotes by TradingView

Michael Geffner is Chief Medical Officer of Immunovant, Inc.. Currently has a direct ownership of 138,160 shares of IMVT, which is worth approximately $3.8 Million. The most recent transaction as insider was on Jul 24, 2024, when has been sold 3,456 shares (Common Stock) at a price of $27.76 per share, resulting in proceeds of $95,938. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 138K
2.44% 3M change
n/a 12M change
Total Value Held $3.8 Million

Michael Geffner Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 24 2024
SELL
Open market or private sale
$95,938 $27.76 p/Share
3,456 Reduced 2.44%
138,160 Common Stock
Apr 24 2024
SELL
Open market or private sale
$94,242 $28.9 p/Share
3,261 Reduced 2.25%
141,616 Common Stock
Apr 02 2024
BUY
Grant, award, or other acquisition
-
54,978 Added 27.51%
144,877 Common Stock
Jan 26 2024
SELL
Open market or private sale
$385,656 $38.18 p/Share
10,101 Reduced 10.1%
89,899 Common Stock
MG

Michael Geffner

Chief Medical Officer
New York, NY

Track Institutional and Insider Activities on IMVT

Follow Immunovant, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IMVT shares.

Notify only if

Insider Trading

Get notified when an Immunovant, Inc. insider buys or sells IMVT shares.

Notify only if

News

Receive news related to Immunovant, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on IMVT